Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangioc
- This topic has 0 replies, 1 voice, and was last updated 5 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
https://www.ncbi.nlm.nih.gov/pubmed/30103095
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.